|Articles|January 4, 2023
Clinscience Joins Forces With OncoBay Clinical
Transaction gives NEUCA Group a 72.6% stake in OncoBay.
Advertisement
Neuca Clinical Trials Inc, a holding company held by Neuca Group, the proprietor of Clinscience international CRO has joined forces with Florida-based oncological CRO, OncoBay Clinical.
The transaction gives NEUCA Group a 72.6% stake in OncoBay. Based in Tampa, Florida, the CRO was founded by Moffit Cancer Center.
Read more about the transaction
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Is Artificial Intelligence Coming for Clinical Research?
2
FDA Approves Imfinzi Plus FLOT for Early and Locally Advanced Gastric and GEJ Cancers
3
Novo Nordisk Submits Higher-Dose Wegovy Injectable for FDA Approval with Priority Voucher
4
FDA Clears Itvisma as First Gene Therapy for Adolescents and Adults With SMA
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
